Table of Content

1 Study Coverage
1.1 Age Related Macular Degeneration Drug Product Introduction
1.2 Market by Type
1.2.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Age Related Macular Degeneration Drug Market by Region
1.4.1 Global Age Related Macular Degeneration Drug Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Age Related Macular Degeneration Drug Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Age Related Macular Degeneration Drug Revenue by Players
2.1.1 Global Age Related Macular Degeneration Drug Revenue by Players (2019-2024)
2.1.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Age Related Macular Degeneration Drug Revenue in 2024
2.2 Global Age Related Macular Degeneration Drug Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Age Related Macular Degeneration Drug Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Applied Genetic Technologies Corp
3.1.1 Applied Genetic Technologies Corp Information
3.1.2 Applied Genetic Technologies Corp Overview
3.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.1.4 Applied Genetic Technologies Corp Related Developments
3.2 Astellas Pharma Inc
3.2.1 Astellas Pharma Inc Information
3.2.2 Astellas Pharma Inc Overview
3.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.2.4 Astellas Pharma Inc Related Developments
3.3 Benitec Biopharma Ltd
3.3.1 Benitec Biopharma Ltd Information
3.3.2 Benitec Biopharma Ltd Overview
3.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.3.4 Benitec Biopharma Ltd Related Developments
3.4 Biokine Therapeutics Ltd
3.4.1 Biokine Therapeutics Ltd Information
3.4.2 Biokine Therapeutics Ltd Overview
3.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.4.4 Biokine Therapeutics Ltd Related Developments
3.5 Crinetics Pharmaceuticals Inc
3.5.1 Crinetics Pharmaceuticals Inc Information
3.5.2 Crinetics Pharmaceuticals Inc Overview
3.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.5.4 Crinetics Pharmaceuticals Inc Related Developments
3.6 Critical Pharmaceuticals Ltd
3.6.1 Critical Pharmaceuticals Ltd Information
3.6.2 Critical Pharmaceuticals Ltd Overview
3.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.6.4 Critical Pharmaceuticals Ltd Related Developments
3.7 Daiichi Sankyo Company Ltd
3.7.1 Daiichi Sankyo Company Ltd Information
3.7.2 Daiichi Sankyo Company Ltd Overview
3.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.7.4 Daiichi Sankyo Company Ltd Related Developments
3.8 Diffusion Pharmaceuticals Inc
3.8.1 Diffusion Pharmaceuticals Inc Information
3.8.2 Diffusion Pharmaceuticals Inc Overview
3.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.8.4 Diffusion Pharmaceuticals Inc Related Developments
3.9 Dong-A Socio Holdings Co Ltd
3.9.1 Dong-A Socio Holdings Co Ltd Information
3.9.2 Dong-A Socio Holdings Co Ltd Overview
3.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.9.4 Dong-A Socio Holdings Co Ltd Related Developments
3.10 Eleven Biotherapeutics Inc
3.10.1 Eleven Biotherapeutics Inc Information
3.10.2 Eleven Biotherapeutics Inc Overview
3.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.10.4 Eleven Biotherapeutics Inc Related Developments
3.11 Elsalys Biotech SAS
3.11.1 Elsalys Biotech SAS Information
3.11.2 Elsalys Biotech SAS Overview
3.11.3 Elsalys Biotech SAS Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.11.4 Elsalys Biotech SAS Related Developments
3.12 Lupin Ltd
3.12.1 Lupin Ltd Information
3.12.2 Lupin Ltd Overview
3.12.3 Lupin Ltd Age Related Macular Degeneration Drug Revenue and Gross Margin (2019-2024)
3.12.4 Lupin Ltd Related Developments
4 Global Age Related Macular Degeneration Drug Market Insights
4.1 Global Age Related Macular Degeneration Drug Market Revenue 2019-2024
4.2 Global Age Related Macular Degeneration Drug Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Age Related Macular Degeneration Drug Revenue by Type
5.2 Global Age Related Macular Degeneration Drug Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Age Related Macular Degeneration Drug Revenue by Application
6.2 Global Age Related Macular Degeneration Drug Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Age Related Macular Degeneration Drug Market Size by Type
7.1.1 Americas Age Related Macular Degeneration Drug Revenue by Type (2019-2024)
7.1.2 Americas Age Related Macular Degeneration Drug Revenue Share by Type (2019-2024)
7.2 Americas Age Related Macular Degeneration Drug Market Size by Application
7.2.1 Americas Age Related Macular Degeneration Drug Revenue by Application (2019-2024)
7.2.2 Americas Age Related Macular Degeneration Drug Revenue Share by Application (2019-2024)
7.3 Americas Age Related Macular Degeneration Drug Market Size by Country
7.3.1 Americas Age Related Macular Degeneration Drug Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Age Related Macular Degeneration Drug Market Size by Type
8.1.1 Europe Age Related Macular Degeneration Drug Revenue by Type (2019-2024)
8.1.2 Europe Age Related Macular Degeneration Drug Revenue Share by Type (2019-2024)
8.2 Europe Age Related Macular Degeneration Drug Market Size by Application
8.2.1 Europe Age Related Macular Degeneration Drug Revenue by Application (2019-2024)
8.2.2 Europe Age Related Macular Degeneration Drug Revenue Share by Application (2019-2024)
8.3 Europe Age Related Macular Degeneration Drug Market Size by Country
8.3.1 Europe Age Related Macular Degeneration Drug Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Age Related Macular Degeneration Drug Market Size by Type
9.1.1 Asia Pacific Age Related Macular Degeneration Drug Revenue by Type (2019-2024)
9.1.2 Asia Pacific Age Related Macular Degeneration Drug Revenue Share by Type (2019-2024)
9.2 Asia Pacific Age Related Macular Degeneration Drug Market Size by Application
9.2.1 Asia Pacific Age Related Macular Degeneration Drug Revenue by Application (2019-2024)
9.2.2 Asia Pacific Age Related Macular Degeneration Drug Revenue Share by Application (2019-2024)
9.3 Asia Pacific Age Related Macular Degeneration Drug Market Size by Region
9.3.1 Asia Pacific Age Related Macular Degeneration Drug Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Type
10.1.1 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Application
10.2.1 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Country
10.3.1 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Age Related Macular Degeneration Drug Industry Trends
11.2 Age Related Macular Degeneration Drug Market Drivers
11.3 Age Related Macular Degeneration Drug Market Challenges
11.4 Age Related Macular Degeneration Drug Market Restraints
12 Age Related Macular Degeneration Drug Forecasted Market Size by Type
12.1 Global Age Related Macular Degeneration Drug Forecasted Revenue by Type
12.2 Global Age Related Macular Degeneration Drug Forecasted Market Size Growth by Type 2024-2030
13 Age Related Macular Degeneration Drug Forecasted Market Size by Application
13.1 Global Age Related Macular Degeneration Drug Forecasted Revenue by Application
13.2 Global Age Related Macular Degeneration Drug Forecasted Market Size Growth by Application 2024-2030
14 Global Age Related Macular Degeneration Drug Market Forecasts
14.1 Global Age Related Macular Degeneration Drug Market Revenue Forecasts 2024-2030
14.2 Global Age Related Macular Degeneration Drug Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Age Related Macular Degeneration Drug Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Age Related Macular Degeneration Drug Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Age Related Macular Degeneration Drug Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Age Related Macular Degeneration Drug Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer